Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Open AccessReview

Interleukin 18 in the CNS

Silvia Alboni1* email, Davide Cervia2* email, Shuei Sugama3 email and Bruno Conti4 email

Department of Biomedical Sciences, University of Modena and Reggio Emilia, Italy

Department of Environmental Sciences, University of Tuscia, Viterbo, Italy

Department of Physiology, Nippon Medical School, 1-1-5 Sendagi Bunkyo-ku, Tokyo 113-8602, Japan

Molecular and Integrative Neurosciences Department, The Scripps Research Institute, CA, USA

author email corresponding author email* Contributed equally

Journal of Neuroinflammation 2010, 7:9doi:10.1186/1742-2094-7-9

Published: 29 January 2010

Abstract

Interleukin (IL)-18 is a cytokine isolated as an important modulator of immune responses and subsequently shown to be pleiotropic. IL-18 and its receptors are expressed in the central nervous system (CNS) where they participate in neuroinflammatory/neurodegenerative processes but also influence homeostasis and behavior. Work on IL-18 null mice, the localization of the IL-18 receptor complex in neurons and the neuronal expression of decoy isoforms of the receptor subunits are beginning to reveal the complexity and the significance of the IL-18 system in the CNS. This review summarizes current knowledge on the central role of IL-18 in health and disease.


© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.